Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Sherlock Biosciences is an engineering biology company offering unparalleled breadth and versatility for diagnostic solutions.
Precede Biosciences is a biotechnology company that provides a blood-based approach to reveal disease-defining transcriptional biology.
Powering precision proteomics to enable to the earliest detection of disease.
Actym Therapeutics is a biotech company that focuses on the discovery and development of novel immuno-oncology therapies to treat cancer.
Predicta Biosciences provides molecular diagnostics and immunotherapeutic discovery services for hematological diseases.
Cubase Bio is a biotechnology business that focuses on spatial biology tools.
SyntaxBio develops genetic programming platform that can program cells without the need for consistent external intervention.
Hepta Bio detect, monitor, and direct the most effective liver treatment.
NuCicer offers high-protein chickpea ingredients with added value in the agri-food system.
Broken String Biosciences is developing a platform of novel sequencing tools to assess genome stability and to unlock the next generation.
Infinity Bio is a biotech company that offers analytics and insight services for antibody reactome profiling against all human viruses.
Arima Genomics is a biotechnology company that develops solutions to drive genomics discovery.
Tagomics transforms disease diagnosis through comprehensive multiomic profiling.
Attovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases.
Pioneering the future of medicine through artificial intelligence and computational biology.
Integrated Biosciences develops next-generation therapeutics.
Genome Medical is a telegenomics technology and services company allowing access to genomic-based medicine.
Fluent Biosciences, a life science company, offering a molecular analysis of cells without the use of complex microfluidic instrumentation.
Pluton Biosciences tests and discovers microbes for the production of a variety of products, primarily pesticides, and pharmaceuticals.
Protillion Biosciences specializes in the design and development of protein-based drugs.
SQZ Biotech features a cell engineering technology designed to deliver a diverse set of materials into patient cells.
Walking Fish Therapeutics is developing a platform to harness B cells’ capability to activate the immune system.
LunaPBC is a healthcare company that transforms health data into health breakthroughs.
Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.
Illumina Ventures has invested in 53 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Illumina Ventures's top investment sectors include Biotechnology, Health Care, Life Science, Medical, Therapeutics. The firm invests across 21 different industry categories.
Among tracked funding rounds, Attovia Therapeutics received $90.0M in a Series C round. Illumina Ventures's total known invested capital is $983.8M.
Illumina Ventures's average investment size is $24.6M across its portfolio of 53 companies.
Recent Illumina Ventures portfolio additions include Sherlock Biosciences, Precede Biosciences, Alamar Biosciences, Actym Therapeutics, Inc., Predicta Biosciences. These companies were founded in 2020 or later.